Sort
82,697 grants matching “vaccine development”
Targeting RIPK3 in Flu-Associated Lung Injury
$702,005Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · AI
Design of fusion inhibitors to block measles host-to-host infection
$701,927Matteo Porotto · Columbia University Health Sciences · R01 · FY2025 · AI
Optimization of HIV vaccines for the induction of cross-reactive antibodies
$701,825Shan Lu · Univ Of Massachusetts Med Sch Worcester · U19 · FY2016 · AI
Optimizing the immunogenicity of next generation polyvalent HIV vaccine formulati
$701,825Shan Lu · Univ Of Massachusetts Med Sch Worcester · U19 · FY2016 · AI
Humoral Correlates of Protection Against HIV
$701,822Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2013 · AI
MOLECULAR GENETICS OF LEISHMANIA
$701,779Stephen M Beverley · Washington University · R01 · FY2015 · AI
IMMUNE RESPONSES TO V. CHOLERAE INFECTION IN BANGLADESH
$701,771Massachusetts General Hospital · U01 · FY2004 · AI
A Novel Recombinant Protein Vaccine Against Ricin Toxin
$701,754University Of Texas Sw Med Ctr/Dallas · U01 · FY2004 · AI
Non-canonical epitope presentation and antigen processing by MHC-E
$701,712Klaus J Frueh · Oregon Health & Science University · R01 · FY2024 · AI
Role of Host Protein Kinase C in Cryptosporidiosis
$701,643Chelsea S. Marie · University Of Virginia · R01 · FY2022 · AI
Visceral Leishmanasis in Bihar State, Indian
$701,577Shyam Sundar · Banaras Hindu University · P50 · FY2010 · AI
Structural Biology of Influenza Epitopes
$701,573Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$701,552David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Durable Vaginal Protection from HIV via mRNA expression of BNABS
$701,552Philip J Santangelo · Emory University · R01 · FY2022 · AI
Gene Expression and Manipulation of Coxiella Burnetii
$701,535Michael F Minnick · Colorado State University · U54 · FY2008 · AI
Immune reconstitution following autologous and allogeneic stem cell transplant
$701,433Frances Hakim · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment Following Hematopoietic Stem Cell Transplantation
$701,425Michael Daniel Keller · Children'S Research Institute · R01 · FY2024 · HL
NOVEL GROUP A STREPTOCOCCUS HUMAN VACCINE CANDIDATES
$701,395James Mallory Musser · Methodist Hospital Research Institute · U01 · FY2007 · AI
Control of antiviral-viral B cell responses by IFNy T-bet and Eomes
$701,261Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2015 · AI
Inflammatory challenge and fear extinction: A model to enhance understanding of posttraumatic stress disorder
$701,260Aoife O'Donovan · Northern California Institute/Res/Edu · R01 · FY2024 · MH
Translation Research in Plasmodium vivax
$701,251University Of Valle · P50 · FY2005 · AI
Experimental human infection with isogenic mutants of Neisseria gonorrhoeae
$701,174Marcia Metzgar Hobbs · Univ Of North Carolina Chapel Hill · U01 · FY2015 · AI
STRUCTURE DRIVEN ANALYSIS OF EBOLA VIRUS RECEPTOR BINDING SITE
$701,172Erica Ollmann Saphire · Scripps Research Institute, The · R01 · FY2010 · AI
Vaccines that Replicate the Neutralization-Competent Structure of the gp41 MPER
$701,154Jamie K Scott · Simon Fraser University · R01 · FY2012 · AI
Natural Immunity Against Chlamydia trachomatis
$701,131Toni Darville · Univ Of North Carolina Chapel Hill · R56 · FY2015 · AI